• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 8, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

‘One size fits all’ medication approach doesn’t work in pregnancy

Bioengineer by Bioengineer
September 8, 2020
in Biology
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: UniSA

New research led by the University of South Australia shows that a blanket approach to prescribing medication during pregnancy may put low birth weight babies at risk for the rest of their lives.

UniSA and New Zealand fetal physiologists say that smaller fetuses metabolise medication taken by the mother in a less efficient way than normal weight babies, which may lead to long term health consequences.

In a review published in Placenta, UniSA Professor Janna Morrison says growth restricted babies may be exposed to higher concentrations of some prescribed or over-the-counter drugs that a woman takes during pregnancy due to a ‘one size fits all’ approach when it comes to dosing.

“If the fetus is smaller and a mother takes 20 milligrams of a drug, it may effectively be a higher dose than in a normal sized baby,” Prof Morrison says. “The actual drug doesn’t make the fetus smaller, but if it is already smaller, the fetus may be less able to metabolise the drug and get rid of it.”

“The idea that a complicated pregnancy is different from a normal pregnancy is new in terms of drugs that may be metabolised by the fetus,” Prof Morrison adds.

The researchers looked at how enzymes that break drugs down are less effective in growth restricted fetuses.

Globally, one in seven babies are born under 2500 grams due to the placenta failing to deliver adequate nutrients and oxygen to the fetus. This can be linked to pre-eclampsia, poor placental development or smoking.

Intrauterine growth restricted (IUGR) babies are at increased risk of diabetes, heart diseases, lower immunity and metabolic diseases throughout their life and may themselves require drug treatments in adulthood. It is not known if they will metabolise these drugs differently.

“We know that most women take prescription or over-the-counter drugs during pregnancy, either to treat a condition they suffer from themselves, or to treat a condition in the unborn child,” according to UniSA Assoc Prof Michael Wiese.

“For example, gestational diabetes affects up to 15 per cent of women, requiring insulin. In Australia, 13 per cent of women take antidepressants during pregnancy, 11 per cent have asthma, 18 per cent have cardiovascular disease and 4.6 per cent have diabetes.

“The use of drugs to treat vomiting is also common, with at least one in five pregnant women taking medications such as Ondansetron,” Assoc Prof Wiese says.

The researchers say that neither the drug companies nor doctors are at fault as there are no existing guidelines for administering dosages based on complicated pregnancies.

“Based on our findings, however, we believe that more work needs to be done to better understand the interaction between pregnancy and fetal growth on how drugs are metabolised. It would then be possible to determine the right dosages for both mother and unborn child,” Prof Morrison says.

The dosages could be lower or higher depending on how the fetus metabolises the drug.

“It doesn’t automatically correlate that a lower dose would be better if the fetus metabolises it faster. It may mean that with some complicated pregnancies, a higher dosage is needed with some drugs. It’s about making sure that the right dose is given to help the mother, without harming the baby.”

###

Media Contact
Candy Gibson
[email protected]

Related Journal Article

http://dx.doi.org/10.1016/j.placenta.2020.07.012

Tags: Developmental/Reproductive BiologyGynecologyMedicine/HealthMetabolism/Metabolic DiseasesPediatrics
Share13Tweet8Share2ShareShareShare2

Related Posts

Tardigrades Reveal Unique Dicer Gene Family Expansions

Tardigrades Reveal Unique Dicer Gene Family Expansions

October 8, 2025
blank

Linkage: Connect DNA Regulatory Peaks to Genes

October 7, 2025

Edo Cattle Market Study: High Tick Diversity Observed

October 7, 2025

Brain-on-a-Chip Technology Uncovers Mechanisms of Brain Damage in Sepsis and Neurodegenerative Diseases

October 7, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1042 shares
    Share 416 Tweet 260
  • New Study Reveals the Science Behind Exercise and Weight Loss

    99 shares
    Share 40 Tweet 25
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    95 shares
    Share 38 Tweet 24
  • Ohio State Study Reveals Protein Quality Control Breakdown as Key Factor in Cancer Immunotherapy Failure

    78 shares
    Share 31 Tweet 20

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Circular RNAs in Mammalian Follicle Development: Insights

Surgical Menopause May Prompt Early Workforce Exit in Women, But Hormone Therapy Shows Promise

Birds Flourish Despite Pollution from Persistent ‘Forever’ Chemicals

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 63 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.